Akebia Therapeutics Inc (AKBA) valuation

AKBA: undervalued.

Figures as of the 2026-11-17 close.

How is AKBA's intrinsic value calculated?

Discounting its cash flows at 6.9% (average of 2 methods) values the shares at $0.97; the price of $0.40 is 59% below that value, and 81% of that value comes from beyond year five. The value is recomputed every night after the US close, from the company's own filings with the SEC and the day's closing price.

Is AKBA in the buy zone?

We call it the buy zone when the price is at least 20% below our estimate of intrinsic value. AKBA trades at $0.40 against a value of $0.97, a margin of safety of +58.7%: it is in the buy zone. A margin of safety is room for our estimate to be wrong, not a forecast.

At what price would AKBA be in the buy zone?

It already is. The buy zone starts at $0.77, which is 20% below our estimate of $0.97, and AKBA trades at $0.40.